Your browser doesn't support javascript.
loading
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.
Bruinooge, Suanna Steeby; Sherwood, Shimere; Grubbs, Stephen; Schilsky, Richard L.
Affiliation
  • Bruinooge SS; American Society of Clinical Oncology.
  • Sherwood S; American Society of Clinical Oncology.
  • Grubbs S; American Society of Clinical Oncology.
  • Schilsky RL; American Society of Clinical Oncology.
J Oncol Pract ; 15(11): 575-583, 2019 11.
Article in En | MEDLINE | ID: mdl-31386607

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Precision Medicine / Molecular Targeted Therapy / Mutation / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Oncol Pract Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Precision Medicine / Molecular Targeted Therapy / Mutation / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Oncol Pract Year: 2019 Type: Article